|
|
 |
|
|
|
| |
|
775 Features
Anti-Obesity Treatments 2007-2012
09 May 08
“By 2010, almost 50 percent of children in North America and 38 percent of those in the European Union will be overweight, research has found”. For pharmaceutical companies looking to target growing successful markets, the anti-obesity drug treatment market offers unique opportunities.
Nini Wei- Visiongain Ltd
What is obesity?
06 May 08
Obesity is the heavy accumulation of fat in your body to such a degree that it rapidly increases your risk of diseases that can damage your health and knock years off your life, such as heart disease and diabetes.
pharmiweb editor
Blood Disorders Market
16 Apr 08
In 2007, blood diseases cost the US’s economy $114bn. In 2004, a reported 232,000 deaths in the US were due to anaemia, myeloproliferative and myelodysplastic disorders, bleeding disorders, white blood cell disorders and thrombosis collectively. From oxygen delivery to immunological defence to clotting, blood has vital physiological functions, and clear, expensive treatments.
Justyna Drozdzal
The Hygiene Hypothesis
15 Apr 08
Why do some people have allergies and some not? And why has the prevalence of allergic disorders been increasing over the past century, especially in industrialised, developed countries?
Mike Wood
Sleep Disorders Market Analysis 2008-2018
11 Apr 08
Which current or future therapies will drive the sleep disorders market from 2008 to 2018?
What is the patient identification rate for each of the therapeutic areas?
What is the present state of the disease awareness?
What R&D opportunities exist for ‘new comers’?
Which key companies are involved in the market?
Justyna Drozdzal
Embarrassed to blow your nose?
01 Apr 08
Forget sweat patches, VPLs and spots…a new survey commissioned by Kleenex® has found that it’s blowing your nose in public that causes us the most embarrassment! The survey of hay fever sufferers reveals that most people prefer a quiet sniff over a good nose blow when out and about. However, allergy specialists warn that the more discreet option actually makes symptoms worse.
Jasmine Richards
Increasing numbers of people are suffering from Asthma
31 Mar 08
Asthma is a significant health problem. Acording to the National Asthma Campaign, the condition continues to grow, and in the UK an estimated 8 million people are diagnosed as having asthma, with 5 million people receiving treatment. The cost of asthma to the NHS is more than £850 million a year.
Mike Wood
Bell Pottinger EXPANDS healthcare business
25 Mar 08
Bell Pottinger Group has formed Bell Pottinger Health, a new business dedicated to leading the expansion of its health franchise with Shipra Singh newly hired as Managing Director. Simultaneously the company has brought in a life science investor relations team led by Mike Wort.
Deborah Cockerill
Versatility: The Key to Pharmaceutical Sales Performance
22 Mar 08
While having a sales force that can deliver your company¡¦s message to physicians and other health care professionals is critical to effective performance, the true key to success is having a sales force that can adapt that message to the needs and preferences of those they call on. Wilson Learning¡¦s research shows that versatile salespeople can be over 50% more successful than their less adaptable counterparts.
This was effectively demonstrated in a study with a large pharmaceutical company.
Natalie Barlow
Chiltern wins 4 'Pharmas'
12 Mar 08
Chiltern, a leading global research organization, is proud to announce that it won 4 ‘Pharmas’ at the PharmaTimes Clinical Researcher of the Year ceremony, including the coveted Clinical Department of the Year.
Peter Lewis
Health Effects of Climate Change in the UK
15 Feb 08
Climate change will have consequences for the health of UK citizens according to a UK government report published on 12th February. The report, called Health Effects of Climate Change in the UK, has been published jointly by the Department of Health (DH) and the Health Protection Agency (HPA).
PharmiWeb.com - editor
Avastin receives broad label extension in Europe for the treatment of patients with metastatic colorectal cancer
30 Jan 08
-The European Commission has granted a broad label expansion for Avastin in combination with any standard chemotherapy in first and later treatment lines for patients with metastatic colorectal cancer.
-This broad approval mean that virtually all patients currently suffering from colorectal cancer that has spread to other parts of the body will now have access to effective new treatments that have proven survival benefits.
-The approval is based on the results of two large internationa
Cat Scott
The Golden Keys of E-Commerce
09 Jan 08
The issue of climate change is now upon us....and the news about ecology is unfolding with many variables.
Here is my take on the image and branding side.
Naseem Javed
Pharma ROI – RIP or SOP?
27 Nov 07
PharmiWeb Solutions’ Managing Director Paul Hartigan was a speaker at the annual conference of the Pharmaceutical Marketing Society in London yesterday, November 26th, hosted by the Royal College of Nurses. He reviews his thoughts on the day here.
Editor
Franchising & Novou-Consumerism in Middle East
25 Sep 07
Two things; firstly among all of the great business concepts of the last few
decades the franchise model has always surfaced to the very top. Secondly,
over the next decade the introduction of hundreds of fresh, locally nurtured franchise concepts emerging within Dubai and the Gulf States will set the stage for a great revolution of nouvo-consumerism. So what are the four key factors driving this movement?
Naseem Javed
|
| |
|
|
submit a feature
